torrent pharmaceuticals

Market Headstart: Nifty seen opening lower; Bharti Airtel, Axis Bank top buys

Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 51 points loss or 0.45 percent. Nifty futures were trading around 11,287-level on the Singaporean Exchange.

Torrent Pharma gets warning letter from USFDA for Gujarat facility

The company does not believe that the warning letter will have an impact of disruption of supplies or the existing revenues from operations of this facility, it added.

Buy Torrent Pharmaceuticals; target of Rs 1750: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1750 in its research report dated July 24, 2019.

Hold Torrent Pharmaceuticals; target of Rs 1720: Sharekhan

Sharekhan recommended Hold rating on Torrent Pharmaceuticals with a target price of Rs 1720 in its research report dated July 23, 2019.

Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show

Nomura expects Torrent to record strong cash flow generation over the next three years

Torrent Pharma Consolidated June 2019 Net Sales at Rs 2,022.00 crore, up 8.01% Y-o-Y

Torrent Pharma Standalone June 2019 Net Sales at Rs 1,603.00 crore, up 10.4% Y-o-Y

Torrent Pharma net profit up 33% to Rs 216 cr in June quarter

The company had posted a net profit of Rs 163 crore for the corresponding period of the previous financial year, Torrent Pharmaceuticals said in a filing to the BSE.

Hold Torrent Pharmaceuticals; target of Rs 1720: Sharekhan

Sharekhan recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1720 in its research report dated July 18, 2019.

Torrent Pharma tanks 6% after USFDA classifies inspection at Dahej facility as OAI

Company does not believe that this inspection classification will have an impact on supplies or the revenues from operations of this facility

Glenmark, Torrent Pharma ink licensing pact to co-market diabetes drug in India

The company, however, did not disclose financial details of the licensing agreement.

Torrent Pharma gains as Credit Suisse stays positive on India biz, sees double digit return

The research house maintained an outperform call on the stock with a target price at Rs 1,750 per share, implying a 14 percent potential upside from current level.

Buy Torrent Pharmaceuticals; target of Rs 1940: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1940 in its research report dated May 21, 2019.

Torrent Pharma Consolidated March 2019 Net Sales at Rs 1,856.00 crore, up 7.78% Y-o-Y

Torrent Pharma Standalone March 2019 Net Sales at Rs 1,357.00 crore, up 1.72% Y-o-Y

Torrent Pharma gains 2% as Ahmedabad unit receives USFDA observations

Torrent Pharma said these observations are procedural in nature and it is confident of addressing them satisfactorily.

Torrent Pharmaceuticals Q4 PAT may dip 12.6% YoY to Rs. 199.3 cr: Kotak

Net Sales are expected to increase by 14.7 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 1,975.8 crore, according to Kotak.

Torrent Pharma net profit jumps over 4-fold to Rs 246 cr in December quarter

Consolidated revenue from operations stood at Rs 2,051 crore for the quarter, against Rs 1,463 crore a year ago.

Torrent Pharma Consolidated December 2018 Net Sales at Rs 2,051.00 crore, up 38.86% Y-o-Y

Torrent Pharma Standalone December 2018 Net Sales at Rs 1,481.00 crore, up 42.27% Y-o-Y

Torrent recalls 16 lots of hypertensive drug from US due to impure API

According to an announcement made by Torrent to the US Food and Drug Administration on January 22, the impurity detected in the API is N-nitrosodiethylamine (NDEA).

Buy Torrent Pharmaceuticals, target Rs 2050: Ashish Chaturmohta

It can be bought at current levels and on dips to Rs 1,860 with a stop loss below Rs 1,780 for the target of Rs 2,050, says Ashish Chaturmohta of Sanctum Wealth Management.

'Dabur, Axis Bank among 5 stocks that could return up to 15% in a month'

On the upside, the index has resistance zone in the region of 10840-10870 levels. But, crossing above 11000 levels on a sustainable basis will confirm the uptrend.

Torrent Pharma gains 4% on redemption of non-convertible debentures

The issued unsecured redeemable non-convertible debentures were worth Rs 500 crore.

Buy Torrent Pharmaceuticals; target of Rs 1850: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated November 05, 2018.